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Abstract
OBJECTIVE: To investigate the effect of a decoc-
tion made from the Traditional Chinese Medicine
Wumei pill, on regulatory T cells and interleukin-10
(IL-10) in a rat model of ulcerative colitis induced by
2,4,6-trinitrobenzene sulfonic acid (TNBS).
METHODS: Rat ulcerative colitis was induced with
TNBS. All modeled rats were randomly divided into
six groups: normal control group; model group; sul-
fasalazine suppositories treatment group; and
high, moderate, and low dosage of Jiaweiwumei
decoction groups (12 rats each). Colon injury index
was evaluated after 14 days. After peripheral blood
lymphocyte separation, CD4 + T cells and CD4 +/
CD25+ T cell percentage was detected by flow cy-
tometry. The content of IL-10 in serum and intesti-
nal mucosa tissue was detected by sandwich en-
zyme-linked immunosorbent assay.
RESULTS: Colon injury indices in the decoction
groups were effectively reduced, compared with
the model group (P < 0.05). Compared with that of
the control group, the CD4+/CD25+ to CD4+ T lym-
phocyte ratio of the model group was significantly
lower, while the decoction treatment improved the
CD4 +/CD25 + to CD4 + T lymphocyte ratio (P <
0.05). The serum and mucosal IL-10 content of the
model group was significantly lower (P < 0.05) than
that in the control group, while the decoction
group had significantly higher serum and intestinal
mucosal IL-10 content than that in the model
group (P < 0.05). The regulatory T cell content was
negatively correlated with the colonic injury index
(r = 0.68, P < 0.05), and positively correlated with
the content of serum IL-10 (r = 0.87, P < 0.05) and
intestinal mucosal IL-10 (r = 0.79, P < 0.05).
CONCLUSION: Jiaweiwumei decoction had signifi-
cant effects on regulatory T cells and IL-10 in rats
with TNBS-induced ulcerative colitis.
© 2015 JTCM. All rights reserved.
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INTRODUCTION
Ulcerative colitis, a refractory chronic inflammatory
bowel disease, has main clinical symptoms of abdomi-
nal pain, diarrhea, mucopurulent bloody stool, and te-
nesmus. Ulcerative colitis is characterized by a slow on-
set, prolonged course, and recurrence. Decades of re-
search have shown that ulcerative colitis incidence has
increased gradually since World War Ⅱ in China.1 As
ulcerative colitis commonly relapses and is intractable,
meaning a poor quality of life for patients, it is neces-
sary to find effective treatments. In recent years, special
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attention has been paid to the content of CD4 +/
CD25 + regulatory T cells (Tregs) and interleukin-10
(IL-10) in the pathogenesis of ulcerative colitis.2,3 Wu-
mei pill in Traditional Chinese Medicine (TCM) is pre-
scribed for the treatment of typhoid ascariasis of the
biliary tract and dysentery in "Shanghan-Lun", which
is a famous clinical tetbook of TCM known in English
as the Treatise on Cold Damage Disorders. However,
Wumei pill's treatment and immunologic mechanisms
on ulcerative colitis are still not clear. This study aimed
to investigate the effect of Jiaweiwumei decoction on
this disease in terms of regulatory T cells and interleu-
kin-10.
MATERIALS ANDMETHODS
Materials and reagents
Adult male Sprague Dawley rats with an initial body
weight of 225-250 g were purchased from the laborato-
ry animal center, The Fourth Military Medical Univer-
sity (license No. SCXK [Army] 2007-007, Xi'an, Chi-
na). Rats were maintained in accordance with the
guidelines for the care and use of laboratory animals in
specific pathogen free conditions.4 Sulfasalazine suppos-
itories (SASP, 250 mg/tablet) was purchased from
Shanghai Sanwei pharmaceutical company (Authorized
document number: H31020450, Shanghai, China).
Fluorescein isothiocyanate (FITC) labeled CD4 + ,
CD25 + antibody and IL-10 Enzyme-linked immuno
sorbent assay (ELISA) Kit were purchased from Bec-
ton, Dickinson, Inc., (San Diego, CA, USA). The tradi-
tional Chinese herbal medicine was composed of: Wu-
mei (Fructus Mume) 16 g, Xixin (Herba Asari Mandsh-
urici) 6 g, Ganjiang (Rhizoma Zingiberis) 10 g, Huan-
glian (Rhizoma Coptidis) 16 g, Danggui (Radix Angeli-
cae Sinensis) 4 g, Fuzi (Radix Aconiti Lateralis Prepara-
ta) 6 g, Huajiao (Pericarpium Zanthoxyli Bungeani) 4 g,
Guizhi (Ramulus Cinnamomi) 6 g, Renshen (Radix
Ginseng) 6 g, Huangbai (Cortex Phellodendri Amuren-
sis) 6 g. Based on the original formula of Wumei pill in
TCM, Ruxiang (Olibanum) 6 g and Moyao (Myrrh) 6 g
were added to create Jiaweiwumei decoction. All of the
herbal drugs were purchased from Beijing Tongrentang
pharmacy (Beijing, China). The decoction was pre-
pared as previously described,5,6 and concentrated with
distilled water before gastric perfusion.
Modeling methods
Rats were fasted for 24 h before the modeling opera-
tion, and then anesthetized with 1.5% sodium pento-
barbital (2 mL/100 g) via intraperitoneal injection.
Rats were fixed in a supine position, and a rubber tube
(diameter 2.0 mm, length 12 cm) lubricated with par-
affin oil, was inserted through the anus slowly until the
splenic flexure. About 8 cm from the anus, a total vol-
ume of 0.92 mL of 2,4,6-trinitrobenzene sulfonic acid
(TNBS, 100 mg/kg) and absolute ethyl alcohol (1∶1)
mixture was slowly injected into the rat. The normal
control group was injected with 0.92 mL saline. After
keeping the rats in an inverted head-down-hip-high po-
sition for about 20 min, rats were allowed to lie and
wake. The results of the analysis of pathological chang-
es determined whether modeling was successful.
Grouping and administration
Rats were randomly divided into six groups: normal
control group; model group; SASP group; and rats in
the high, moderate, and low decoction dose groups,
which received 1.428, 0.71, and 0.357 g/mL decoc-
tion, respectively, 2 mL orally, once daily. The SASP
group received SASP suspension (0.035 g/mL), 2 mL
orally, once daily. The normal control group received
distilled water 2 mL orally, once daily. All rats were
treated for 14 days.
Colon tissue score
After day 14 of treatment, all rats were anesthetized
with chloral hydrate. The mesentery was longitudinally
opened, and intestinal contents were washed out with
cold saline. The colon was flattened. Colon mucosa
damage, e.g. congestion, edema, erosion, ulcers, pseu-
do membrane extent, and area of pathological changes
were observed and recorded. The colon tissue morphol-
ogy score was made according to the reference in Table
1, and the colon tissue was scored according to the
standards of grading.7
Detection of Peripheral blood mononuclear cells
According to the literature,8 a peripheral blood mono-
nuclear cell (PBMC) suspension was isolated and pre-
pared from rat peripheral blood. FITC labeled antibod-
ies (Becton Dickinson Inc.), 20 μL, were added into
100 μL PBMC suspension, and then mixed before a
dark incubation at room temperature for 20 min. Sam-
Score
0
1
2
3
4
5
Colonic mucosa tissue characteristics observed by naked eye
No damage
Mucosal hyperemia, edema, no ulcer
Mucosal hyperemia, edema, mild erosion, no ulcer
Mucosal hyperemia, edema, moderate erosion, single ulcer
Mucosal hyperemia, edema, moderate erosion, more than one ulcer
Mucosal hyperemia, edema, severe erosion, ulcer size > l cm
Table 1 Ulcerative colon mucosa injury score criteria
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ples were then centrifuged at 980 ×g for 5 min. The su-
pernatant was removed, and PBS was used to re-sus-
pend cells. Flow cytometry was used to detect the per-
centages of CD4+ and CD4+/CD25+ T cells.
IL-10 detection
Serum preparation: Rats were anesthetized with 1.5%
sodium pentobarbital (2 mL/100 g) via intraperitoneal
injection. Blood was obtained via abdominal aorta.
Blood was allowed to clot for 20 min, and then centri-
fuged 1600 × g for 15 min. Serum was separated and
kept at﹣20℃.
Tissue homogenate preparation: 6-8 cm of colon from
2 cm upward was cut removed along the longitudinal
axis of the mesentery lumen. Lesions (pathological tis-
sues) 0.1 g were obtained and cut into pieces. Then,
500 μL of 0.9% sodium chloride solution was added
to prepared 20% homogenate, centrifuged to get the
supernatant, and kept at ﹣20 ℃ . IL-10 was detected
by double antibody sandwich ELISA (BD Inc., San Di-
ego, CA, USA), in strict accordance with the kit in-
structions.
Statistical analysis
SPSS 13.0 (version 13, Chicago, IL, USA) software
was used to process data, which were represented by
mean ± standard deviation ( xˉ ± s). One-way analysis
of variance was performed and Student-New-
man-Keuls test was used to compare differences be-
tween two groups. Correlation analysis of regulatory T
cell quantity and each index were analyzed using Spear-
man analysis. P ≤ 0.05 was considered significant.
RESULTS
Comparison of colon injury index
Colon injury index analysis showed statistically signifi-
cant difference between the model group and normal
control group (P < 0.05). There were significant differ-
ences between each treatment group and model group
(P < 0.05). There was no statistically significant differ-
ence between the decoction treatment groups and the
SASP treatment group (P > 0.05), as seen in Table 2.
These results suggest that Jiaweiwumei decoction effec-
tively reduced colon injury from ulcerative colitis in
rats induced by TNBS, with equivalent efficacy to
SASP.
T lymphocyte subset analysis
Peripheral blood T lymphocyte subset analysis showed
that there was no significant difference in peripheral
blood CD4 + T lymphocyte percentage among the
groups (P > 0.05). Compared with that in the control
group, the ratio of CD4+/CD25+ to CD4+ T cells was
significantly lower in model group rats. Both the SASP
and the decoction treatment groups had significantly
higher CD4 +/CD25 + to CD4 + T cell ratios (P <
0.05). There were no significant differences between
the decoction treatment groups and the SASP group in
the T cell ratio (P > 0.05, Table 2).
Comparison of IL-10 contents in serum and
intestinal mucosa
The IL-10 content in serum and intestinal mucosa of
the model group rats was significantly lower than that
in the control group (P < 0.05). Meanwhile, the SASP
and decoction treatment could effectively improve se-
rum and intestinal mucosal IL-10 content (P < 0.05).
There was no significant difference in the content of
IL-10 in serum between the decoction groups and
SASP group (P > 0.05). Compared with the high dose
group, the other treatment groups had a significantly
lower IL-10 content in the intestinal mucosa (P <
0.05, Table 2).
Correlation analysis between the Treg cell content,
colonic damage index, and IL-10 level
Correlation analysis indicated that Treg cell content
and colon injury index (except the control group) were
negatively correlated (r = 0.68, P < 0.05). Treg cell con-
tent was positively correlated with that of serum IL-10
(r = 0.87, P < 0.05), and correlated positively with in-
testinal mucosal IL-10 content (r = 0.79, P < 0.05).
Group
Normal control
Model
SASP
Low dose
Moderate dose
High dose
n
12
12
12
12
12
12
Score
0
4.4±0.5
1.3±0.6a
1.6±0.2a
1.3±0.5a
1.3±0.3a
CD4+ T lymphocyte
percentage (%)
35.87±6.89
32.91±7.39
34.56±6.29
35.21±7.23
34.81±6.21
34.35±6.28
Ratio of CD4+
CD25+ T /CD4 + T
10.70±1.64
4.59±1.28b
7.48±0.54a
7.01±0.62a
7.89 ±0.34a
8.56±0.28a
Serum IL-10
(ng/mL)
38.78±7.09
18.51±3.81b
23.92±5.24ab
25.32±6.41ab
33.57±5.32ab
31.24±6.33ab
Intestinal mucosa
IL-10 (ng/L)
69.1±9.6
33.6±6.1b
51.1±8.2abc
42.1±9.1abc
51.1±8.2abc
62.3±10.9a
Table 2 Colon injury index, peripheral blood CD4+ T lymphocyte subsets (%), and content of IL-10 ( xˉ ± s)
Notes: the normal control group received distilled water 2 mL orally, once daily. High, moderate, and low dose groups received 1.428,
0.71, and 0.357 g/mL decoction, respectively, 2 mL orally, once daily. The SASP group received SASP suspension (0.035 g/mL), 2 mL
orally, once daily. All rats were treated for 14 days. CD: cluster of differentiation; IL: interleukin; SASP: sulfasalazine suppositories. Com-
pared with the model group, aP < 0.05; compared with the Normal control group, bP < 0.05; compared with the high dose group, cP <
0.05.
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DISCUSSION
The results of this study indicate that the percentage of
CD4+/CD25+ T regulatory lymphocytes and the level
of IL-10 in the peripheral blood of ulcerative colitis
rats was lower than that of the normal rats, which is
consistent with previous clinical and animal experimen-
tal results.9-12 The results of this study also indicate that
the TCM Jiaweiwumei decoction at high, middle, and
low doses and SASP all decreased the colon index to
some extent. This result indicates that the decoction
treatment could effectively reduce the colon injury in-
duced by TNBS via increased IL-10 in serum and in-
testinal mucosa and an increased percentage of CD4+/
CD25+ T regulatory cells in peripheral blood. In addi-
tion, correlation analysis of the experimental results
shows that the percentage of CD4+/CD25+ T regulato-
ry cells in the peripheral blood was negatively correlat-
ed with the scores of colon injury index, and was posi-
tively correlated to IL-10. Meanwhile, our results sug-
gest that determination of CD4+/CD25+ T regulatory
cells in the peripheral blood could reflect the severity
of ulcerative colitis, and could be regarded as an indica-
tor of efficacy evaluation.
In TCM, the Wumei pill formula is prescribed for the
treatment of typhoid ascariasis of the biliary tract and
dysentery in Shang Han Lun. Clinical research has con-
firmed its curative effect in treatment of chronic ulcer-
ative colitis.13-16 Our results indicate that the therapeu-
tic effect of the decoction on experimental ulcerative
colitis was significant, and its mechanism was potential-
ly related to a reduction in the intestinal mucosal im-
mune response by up regulating the expression of IL-
10 and T regulatory cells, which plays a role in muco-
sal repair.
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